Skip to the catalogue
halfrx

Empower Pharmacy: what the FDA record shows

Empower is one of the few compounding pharmacies in this category that is registered with the FDA rather than only with a state, which means its inspections are public. They are also the reason to read this page: the FDA has issued the company three warning letters, and the most recent two arrived on the same day in April 2025.

Houston, Texas.

What does the FDA record show for Empower Pharmacy?

Empower Pharmacy appears in the FDA's register of outsourcing facilities as Empower Pharma, Houston, TX, registered since 2016-07-16. Its last inspection was 2025-11-14, and investigators left a Form 483, with the action based on that inspection recorded as open. The FDA has issued 3 warning letters touching this company, the most recent dated 2025-04-02, each linked below and opened before being cited here. The wider number is the one worth carrying away: of the 97 registered outsourcing facilities in the United States, 40 have never been inspected, and of the 57 that have, 55 were handed a Form 483 — only 2 came away without one. And whichever pharmacy fills your prescription, no seller on this site tells you which one it is.

The federal record

Listed in the FDA register asEmpower Pharma, Houston, TX
Initial registration2016-07-16
Last inspection2025-11-14
Form 483 issuedyes — read the 483
Action based on last inspectionOpen

Read from the FDA register of outsourcing facilities on 2026-08-28. The FDA marks that page current as of 2026-08-25.

Warning letters

  1. 2025-04-02Compounding Pharmacy/Adulterated Drug Products

    Addressed to Empower Clinic Services, LLC dba Empower Pharmacy, Houston, TX.

    The letter follows an inspection running from 24 September to 4 October 2024, and its language is unusually direct for the genre. FDA investigators recorded “serious deficiencies in your practices for producing drug products, which put patients at risk”, and found that products intended to be sterile had been “prepared, packed, or held under insanitary conditions, whereby they may have become contaminated with filth or rendered injurious to health” — which makes them adulterated under section 501(a)(2)(A) of the Food, Drug, and Cosmetic Act. A Form 483 was issued at the close of the inspection on 4 October 2024, and the company responded twice before the letter was sent.

    Read the letter on fda.gov

  2. 2025-04-02Compounding Pharmacy/Adulterated Drug Products

    Addressed to Empower Clinic Services, LLC dba Empower Pharma.

    A second letter to the same company under its other trading name, issued the same day and carrying the same subject. Two letters on one date to one company is worth noticing: it means the FDA treated the entities separately rather than folding them into one action.

    Read the letter on fda.gov

  3. 2021-10-15Compounding Pharmacy/Adulterated Drug Products

    Addressed to Empower Clinic Services, LLC dba Empower Pharmacy.

    The earlier letter, under the same subject heading as the 2025 pair. It matters mainly for what it establishes about sequence: the 2025 findings were not a first encounter.

    Read the letter on fda.gov

What was checked and not found

  • No recall is recorded against the facility in the FDA register.

Which seller uses Empower Pharmacy?

Nobody publishes it. 11 sellers were checked on the pages a buyer reads before ordering, last on 2026-08-26, and none names a compounding pharmacy at all. Since the pharmacy is what decides the quality of a compounded drug, that omission is the most consequential blank on a checkout page. The full disclosure audit lists what each seller was asked and what it said.

Questions

Is Empower Pharmacy inspected by the FDA?
Yes, because it is a registered outsourcing facility, which puts it on the FDA's inspection schedule and makes the outcome public. Its last inspection was 2025-11-14, and it produced a Form 483. That is more than can be said for most of the register: of the 97 facilities on it, 40 have never been inspected at all.
Which telehealth company uses Empower Pharmacy?
Unknown, and that is a finding rather than a research failure. 11 sellers were checked on the pages a buyer actually reads before ordering, last on 2026-08-26, and not one of them names a compounding pharmacy. The pharmacy decides the quality of a compounded drug, and it is the single fact the seller does not put on the page.
Has Empower Pharmacy had an FDA warning letter?
3 are on record, and each is linked above. A warning letter is not a closure or a fine — it is the FDA saying practices appear to violate the law and giving the company a chance to correct them. What it gives a buyer is a dated, public account of what investigators found inside the building.
Is Empower Pharmacy FDA approved?
No compounding pharmacy is, and the phrase does not apply. FDA approval attaches to a drug that has been through trials and holds a label; compounding is an exemption from that approval, not a version of it. What Empower does have is FDA registration as an outsourcing facility, which is a different and much weaker thing: it puts the facility on the FDA's inspection schedule and makes the results public. Those results are on this page.
Does a warning letter mean Empower is shut down?
No. A warning letter is the FDA telling a company its practices appear to violate the law and giving it the chance to correct them; it is not a closure, a recall or a fine. The register still lists the facility as registered, with the action based on its last inspection shown as open. What the letter changes is what a buyer knows: sterile products from this facility were found to have been made under insanitary conditions in an inspection the FDA describes as putting patients at risk.

Other pharmacies checked

Last updated 2026-08-28FDA register and warning letter database read